This page is updated frequently with new Lactobacillus-related patent applications.
|Compositions containing boric acid and a mixture of lactobacillus|
The present invention relates to a new composition, containing boric acid and a mixture of at least two lactobacilli selected from l. Rhamnosus, l.
Pizeta Group Srl
|Sleep quality improver|
Provided is a novel agent for improving sleep quality. An agent for improving sleep quality containing, as an active ingredient, bacterial cells of lactobacillus casei and/or a treated product thereof..
Kabushiki Kaisha Yakult Honsha
|Probiotics and methods of use|
The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by lactobacillus paracasei cba l74, international depository accession number lmg p-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring..
H.j. Heinz Company Brands Llc
|Methods for discriminating interspecific relationships and intraspecific relationships of lactic acid bacteria of lactobacillus casei group|
Degenerate primers for amplifying fragments of the nucleotide sequences of mutl and dnaj genes of a lactic acid bacterium of lactobacillus casei group are provided. Methods and kits for discriminating interspecies and intraspecies of a lactic acid bacteria of lb.
Food Industry Research And Development Institute
|Lactobacillus-based ecoli inhibition|
A method of reducing growth of pathogenic bacteria in a gastrointestinal tract of an animal by providing to the animal a composition having 1×1013 cfu of lactobacillus probiotic microorganisms per kilogram of feed. When 1×104 viable cells of the lactobacillus probiotic are added to 1×104 viable cells of escherichia coli in a solution of mrs broth in a test tube and incubated in a water bath at 37° c.
|Lactobacillus rhamnosus rht-3201 conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseases|
The present invention relates to heat-killed lactobacillus rhamnosus conjugated to a polysaccharide polymer binder, a preparation method therefor and a use thereof. The heat-killed lactobacillus rhamnosus conjugated to a polysaccharide polymer binder of the present invention has an excellent therapeutic effect for atopic diseases, and particularly has high industrial applicability because membrane adhesion competitiveness, which is an advantage of existing lactic acid bacteria, is significantly improved, thereby exhibiting dermatitis preventing, alleviating and treating effects of the same level as steroid-based drugs..
Il Dong Pharmaceutical Co., Ltd.
|Lactic acid bacteria capable of preventing and/or treating senescence and dementia|
The present invention provides a novel lactic acid bacterium having antioxidant and anti-aging functions and a dementia alleviation effect, and more specifically, provides lactobacillus pentosus var. Plantarum c29 kccm11291p and lactobacillus curvatus c3 kccm430009.
University-industry Cooperation Group Of Kyung Hee University
|Therapy for use in the treatment of tumors, acquired immunodeficiency syndrome and leukemias by dual immune biostimulation|
A composition for human and animal use as a therapy for the treatment of tumors, acquired immunodeficiency syndrome and leukemias is described. The composition, for human and animal use as an antitumor agent has a strain of bacteria lactobacillus reuteri lre 03 dsm 23879 which is able to strongly stimulate the production of pro-inflammatory cytokines (th1) interferon inf-gamma, the cytokines exhibiting a marked antitumor activity, and/or a strain of bacteria lactobacillus salivarius ls06 dsm 26037 which is able to strongly stimulate the production of dendritic cells, the dendritic cells also exhibiting a marked antitumor activity..
|Novel lactobacillus plantarum and composition containing same|
The present invention provides lactobacillus plantarum cjlp55 kctc 11401bp, a composition for treating bowel disease containing the lactobacillus, and a composition for immunological enhancement containing the lactobacillus.. .
Cj Cheiljedang Corp.
|Novel lactic acid bacterium and use thereof|
A new lactobacillus mali that can be used for preventing or treating a metabolic syndrome is provided. A method for preventing or treating obesity, diabetes or a complication of diabetes by using the lactobacillus mali is also provided..
National Taiwan University
Use of lactobacillus paracasei for promoting recovery of the intestinal microbiota diversity after dysbiosis
The present invention provides the use of lactobacillus paracasei, for maintaining or increasing the intestinal microbiota diversity in a subject having dysbiosis.. .
Institut National De La Recherche Agronomique
Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after dysbiosis
The present invention provides the use of lactobacillus rhamnosus, for maintaining or increasing the intestinal microbiota diversity in a subject.. .
Institut National De La Recherche Agronomique
Nutraceutical supplement with lactobacillus rhamnosus
Compositions and uses thereof include an admixture of a probiotic and natural phytochemicals that can affect an individual's stem cells and the inflammatory process to reduce underlying symptoms of various health issues, including arthritis, aging, and physical or athletic injuries, thereby facilitating healing and repair of tissues.. .
Nwo Stem Cure, Llc
Lactobacillus salivarius for the treatment of mastitis
The invention relates to a new strain of lactobacillus salivarius, products containing the new strain, the use thereof in and methods for the treatment and/or prevention of inflammation and/or infection in breast or udder tissue, particularly in a mammary gland of a human female. The inflammation and/or infection is preferably mastitis..
Method for producing rare fatty acid using novel enzyme, and novel rare fatty acid
The present invention provides production of hydroxylated fatty acid by a hydration reaction using a novel enzyme derived from lactobacillus and using fatty acid as a substrate, and further, a production method of oxo fatty acid by an enzyme reaction or chemical oxidation reaction using the hydroxylated fatty acid as a substrate. In addition, a valuable novel rare fatty acid obtained by such production method is also provided..
Nitto Pharmaceutical Industries, Ltd.
Compositions and methods for inhibiting pathogenic growth
The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of e. Coli o157:h7 and other pathogenic bacteria.
Chr. Hansen A/s
Lactobacillus crispatus and application thereof
The present invention discloses lactobacillus crispatus 262-1 and an inoculum comprising such strain and application thereof. The lactobacillus crispatus 262-1 is a new strain of lactobacillus genus and is preserved in the china general microbiological culture collection center with a preservation number of cgmcc no.
Suzhou Osel Bio-pharm Co., Ltd.
Prevention of pregnancy complications by probiotic administration
Methods for the treatment of pregnancy complications through immune modulation are disclosed. Also disclosed are probiotic compositions capable of inducing an anti-inflammatory immune response in a subject.
Therapeutic Solutions International, Inc.
Peptide having fungicidal activity, isolated from lactobacillus plantarum yml007
The present invention relates to a peptide having a fungicidal activity, isolated from lactobacillus plantarum yml007, and provides a fungicidal peptide comprising the amino acid sequence of seq id no: 1. In addition, the present invention provides a fungicidal composition or a composition for food preservation, containing the peptide as an active ingredient.
Research Cooperation Foundation Of Yeungnam University
Materials and methods for improving immune responses and skin and/or mucosal barrier functions
The subject invention provides compositions and methods for treating human dermatological conditions by employing a microbiome-centered treatment approach. Preferred embodiments of the invention provide pharmaceutical and cosmetic compositions, and the methods of using the same, comprising a strain of lactobacillus fermentum bacterium, or bioactive extracts thereof, derived from human microbiota and capable of growing in biofilm phenotype..
Quorum Innovations, Llc
Mucoadhesive sustained-release vaginal tablet
The disclosure relates to a mucoadhesive sustained-release vaginal tablet including at least one probiotic strain of the genus lactobacillus compressed with an excipient suitable for conferring upon the tablet the properties of vaginal wall mucoadhesion and sustained release.. .
Biocatalytic composition for treatment of substrates
Biocatalytic composition to be used in the agricultural, zootechnical and environmental recovery fields, to transform substrates which is reacted with, to non-polluting substances, including a component with coenzymatic activity including vitamin a, vitamin d3, vitamin e, propylgallate, raw fats, raw proteins; a component with enzymatic activity including bacillus licheniformis, bacillus subtilis, bacillus thuringiensis, bacillus spp, aspergillus oryzae, aspergillus niger, lactobacillus bifidus, lactobacillus acidophilus, amylase, protease, lipase, cellulase, gumase; and a component including substances regulating ph, including humic acids, fulvic acids, crenic acids, apocrenic acids, vitamin a, vitamin d3, vitamin pp, arthrospira maxima, among others.. .
Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
The lactobacillus paracasei mcc1849 (nite bp-01633) strain, which has a high il-12 production-promoting action, is used as an ingredient of a drug, food or drink, or feed used for promotion of il-12 production, immunostimulation, antivirus, or the like.. .
Morinaga Milk Industry Co., Ltd.
New strains of the genus lactobacillus and use thereof
This invention provides novel strains of the genus lactobacillus which can be used to produce pharmaceutical products with probiotic properties for human or veterinary use. The strains of this invention possess metabolic features that are particularly suitable for treatment of disorders related to lactose malabsorption and intolerance, fructose malabsorption and intolerance, and bloating..
Vaginal composition and use thereof
A use of isomaltulose in the preparation of a vaginal composition, wherein the amount of isomaltulose used is 0.05-20% (w/w). A vaginal composition contains 0.05-20% (w/w) of isomaltulose.
Singapore Ze&z International Pte. Ltd
Novel lactobacillus plantarum and composition containing the same
The present invention provides lactobacillus plantarum cjlp56 kctc 11402bp, a composition containing the lactobacillus for treating intestinal diseases, and a composition containing the lactobacillus for enhancing immunity.. .
Cj Cheiljedang Corp.
Lactic acid bacterium lactobacillus fermentum isolated from adults in longevity village, helpful for defecation
The invention relates to a novel strain, lactobacillus fermentum strain, and a use thereof. Specifically, novel lactobacillus fermentum pl9988, novel lactobacillus fermentum pl9037, novel lactobacillus fermentum pl9038, novel lactobacillus fermentum pl9039 and novel lactobacillus fermentum pl9040 strains, isolated from adults in a longevity village, and culture fluids thereof: have no antibiotic resistance transfer; have excellent intestinal cell adhesiveness, acid resistance and bile resistance; inhibit harmful pathogenic organisms in intestines; and have an immunity-enhancing effect, an endotoxin shock suppression effect and an antioxidant effect.
Pl Bio Co., Ltd.
Process and composition for manufacture of a microbial-based product
Processes to produce microorganisms that can be incorporated into a microbial-based product that results in high viable cell yields and shelf-stable products are disclosed. These microbial-based products are useful for inhibiting pathogenic growth and as a food additive.
Pharmaceutical composition including dead cells of lactobacillus acidophilus lb to treat or prevent allergic disease
Disclosed is a pharmaceutical composition including dead cells of lactobacillus acidophilus lb strain as an active ingredient for treating or preventing an allergic disease, and may be used to treat and prevent ige-mediated allergic diseases and non-ige-mediated allergic diseases such as atopic dermatitis, allergic rhinitis, allergic conjunctivitis, urticaria, and pollinosis by reducing the total content of ige in the blood.. .
Recombinant lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses
Methods and compositions for treating or preventing inflammatory disorders are provided. The compositions of the invention comprise a recombinant bacterium genetically modified to decrease the display of lipoteichoic acid on the cell surface.
Supplement for improving immunotolerance, intestinal environment and intestinal tract barrier
A supplement for improving immunotolerance, intestinal environment and intestinal tract barrier for the purpose of improving intestinal vulnerability, food intolerance or allergy, systemic allergy, autoimmune diseases and systemic inflammatory diseases by immune reactions which is obtained by mixing an ingredient (a) comprising at least one of a probiotic that is any one of lactic acid bacteria, lactobacillus bifidus, saccharified bacteria, natto bacteria and yeast fungus, or a mixture thereof, a biogenic that is a bacteria-producing substance such as lactic acid bacteria, and a prebiotic is indigestible food ingredients such as oligosaccharide, dietary fiber, substance stimulating production of lactobacillus bifidus, and others or a mixture thereof and an ingredient (b) comprising at least one of l-glutamine, zinc, vitamin a and vitamin d.. .
Oral care product formulation
A probiotic formulation includes the following: lactobacillus acidophilus comprising 15.0% to 40.0% per mass of the probiotic formulation; lactobacillus reuteri comprising 5.0% to 20.0% per mass of the probiotic formulation; lactobacillus salivarius comprising 5.0% to 20.0% per mass of the probiotic formulation; lactobacillus paracasei comprising 5.0% to 20.0% per mass of the probiotic formulation; streptococcus thermophiles comprising 5.0% to 20.0% per mass of the probiotic formulation; streptococcus salivarius blis k-12 comprising 5.0% to 30.0% per mass of the probiotic formulation; streptococcus salivarius blis m-18 comprising 5.0% to 30.0% per mass of the probiotic formulation; zinc oxide comprising 0.2% to 5.0% per mass of the probiotic formulation; hydroxyapatite comprising 0.1% to 25.0% per mass of the probiotic formulation; and dicalcium phosphate comprising 0.1% to 5.0% per mass of the probiotic formulation. The probiotic formulation may be formed into a lozenge or a gum..
Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium
The present invention provides a method for preventing or treating a functional gastrointestinal disorder in a subject in need thereof that includes a step of administering a composition, wherein the composition includes an effective amount of lactobacillus plantarum subsp. Plantarum ps128 and a carrier.
National Yang-ming University
Lactobacillus plantarum inducia dsm 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against clostridium difficile
A microorganism strain lactobacillus plantarum inducia dsm 21379 for use as hypocholesterolemic, antimicrobial and anti-oxidative agent and as enhancer of the natural defense potential of a subject. L.
Tervisliku Pllma Biotehnoloogiate Arenduskeskus OÜ (bio-competence Centre Of
Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
The present invention is directed to methods and compositions for typing of lactobacillus buchneri bacterial strains, detecting the presence of a l. Buchneri in a sample, identifying a strain of l.
North Carolina State University
Method of improving immune function in mammals using lactobacillus strains with certain lipids
A method of improving immune-function in mammals using selected 3-hpa producing lactic acid bacteria with a medium chain triglyceride (mct) oil.. .
Composition comprising lactobacillus plantarum
The present invention relates to strain of lactobacilli and compositions containing the strain for use in modifying the absorption of cholesterol in an individual or the treatment of heart disease, diabetes or obesity.. .
Fermented coconut antimicrobial product
An antimicrobial and antifungal composition and method is disclosed. The antimicrobial and antifungal composition is prepared by a process of using lactobacillus to ferment cocos nucifera fruit..
Active Micro Technologies, Llc
Fermentation process for producing chemicals
The invention refers to a method of biotransforming a carbohydrate of a raw material into a chemical, by cultivating lactobacillus diolivorans in the presence of the raw material to produce a chemical substance, and isolating the chemical substance in the purified form, and the use of l. Diolivorans in one of a series of biotransformation methods, wherein carbohydrates from at least two different carbohydrate sources of low purity are transformed into chemicals..
Cvs transplantation for treatment of bacterial vaginosis
Methods and materials for treating bacterial vaginosis (“bv”) are provided. Cervicovaginal secretions (“cvs”) from a woman with vaginal microbiota dominated (>50%) by one of the species of lactobacillus typically found in the human vagina, e.g.
The Johns Hopkins University
Intestinal barrier function enhancer containing lactic acid bacteria
Provided are an intestinal barrier function enhancer capable of enhancing intestinal barrier function and thereby capable of preventing or treating metabolic syndrome, and a drug and a food or drink containing the same. An intestinal barrier function enhancer containing cells or a treated cell product of lactobacillus crustorum.
Suntory Holdings Limited
Probiotic strain of lactobacillus reuteri exhibiting anti-helicobacter activity, a probiotic or biotherapeutic product comprising said strain, and the use thereof
The invention relates to a new strain of lactobacillus reuteri isolated from the human stomach, exhibiting antioxidant and antimicrobial activity, in particular an anti-helicobacter effect, considerable resistance to the conditions of the gastric ecosystem, and the capacity to adhere to the epithelium. The invention also relates to a probiotic or biotherapeutic product which contains the strain of l.
Consejo Superior De Investigaciones Científicas ( Csic)
Nutritional supplement and process of preparation
Processes for producing a nutritional supplement that contains sulforaphane, and supplements formed thereby. Such a process includes combining a cruciferous vegetable, for example, broccoli sprouts, with at least one strain of lactobacillus to form a mixture, causing the mixture to undergo lactic fermentation, transform a glucosinolate within the cruciferous vegetable to sulforaphane, and yield a fermented mixture that contains sulforaphane, and then producing from the fermented mixture a supplement that can be ingested by an individual..